Skandinaviska Enskilda Banken Ab (Publ) Arvinas, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $20.7 Billion
- Q2 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Arvinas, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 9,806 shares of ARVN stock, worth $265,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,806
Previous 9,806
-0.0%
Holding current value
$265,840
Previous $404,000
35.4%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARVN
# of Institutions
222Shares Held
68.8MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$182 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$181 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$170 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$108 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$81 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.44B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...